Skip to main content
Top
Published in: AIDS and Behavior 2/2012

01-02-2012 | Original Paper

Real-Time Electronic Adherence Monitoring is Feasible, Comparable to Unannounced Pill Counts, and Acceptable

Authors: Jessica E. Haberer, Gregory K. Robbins, Michele Ybarra, Alexandra Monk, Kathleen Ragland, Sheri D. Weiser, Mallory O. Johnson, David R. Bangsberg

Published in: AIDS and Behavior | Issue 2/2012

Login to get access

Abstract

Second generation electronic medication adherence monitors provide real-time data on pill bottle opening behavior. Feasibility, validity, and acceptability, however, have not been established. Med-eMonitor is a multi-compartment adherence device with reminder and education capacity that transmits data through a telephone connection. Monthly adherence levels were measured for 52 participants over approximately 3 months using the Med-eMonitor (unadjusted and adjusted for participant confirmed dosing) and unannounced pill counts. HIV RNA was assessed before and after the 3-month period. Acceptability of Med-eMonitor was determined. Over 92% of Med-eMonitor data was transmitted daily. Unannounced pill counts significantly correlated with adjusted Med-eMonitor adherence (r = 0.29, P = 0.04). HIV RNA significantly correlated with unannounced pill counts (r = −0.34, P = 0.02), and trended toward a significant correlation with unadjusted Med-eMonitor adherence (r = −0.26; P = 0.07). Most, but not all, participants liked using the Med-eMonitor. Med-eMonitor allows for real-time adherence monitoring and potentially intervention, which may be critical for prolonging treatment success.
Literature
1.
go back to reference Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30.PubMed Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30.PubMed
2.
go back to reference Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357–66.PubMedCrossRef Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357–66.PubMedCrossRef
3.
go back to reference Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181–3.PubMedCrossRef Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181–3.PubMedCrossRef
4.
go back to reference Wood E, Hogg RS, Yip B, et al. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 × 10(9) cells/L. Ann Intern Med. 2003;139(10):810–6.PubMed Wood E, Hogg RS, Yip B, et al. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 × 10(9) cells/L. Ann Intern Med. 2003;139(10):810–6.PubMed
5.
go back to reference Lu M, Safren SA, Skolnik PR, et al. Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav. 2008;12(1):86–94.PubMedCrossRef Lu M, Safren SA, Skolnik PR, et al. Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav. 2008;12(1):86–94.PubMedCrossRef
6.
go back to reference Grossberg R, Gross R. Use of pharmacy refill data as a measure of antiretroviral adherence. Curr HIV/AIDS Rep. 2007;4(4):187–91.PubMedCrossRef Grossberg R, Gross R. Use of pharmacy refill data as a measure of antiretroviral adherence. Curr HIV/AIDS Rep. 2007;4(4):187–91.PubMedCrossRef
7.
go back to reference Petersen ML, Wang Y, van der Laan MJ, et al. Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis. 2007;45(7):908–15.PubMedCrossRef Petersen ML, Wang Y, van der Laan MJ, et al. Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis. 2007;45(7):908–15.PubMedCrossRef
8.
go back to reference Bangsberg DR, Deeks SG. Spending more to save more: interventions to promote adherence. Ann Intern Med. 2010;152(1):54–6; W-13. Bangsberg DR, Deeks SG. Spending more to save more: interventions to promote adherence. Ann Intern Med. 2010;152(1):54–6; W-13.
9.
go back to reference Bendle S, Velligan D, Mueller J, et al. The Med-eMonitor™ for improving adherence to oral medication in schizophrenia. Schizophr Bull. 2005;31(2):519. Bendle S, Velligan D, Mueller J, et al. The Med-eMonitor™ for improving adherence to oral medication in schizophrenia. Schizophr Bull. 2005;31(2):519.
10.
go back to reference Ruskin PE, Van Der Wende J, Clark CR, et al. Feasability of using the Med-eMonitor™ system in the treatment of schizophrenia: a pilot study. Drug Inf J. 2003;38:1–8. Ruskin PE, Van Der Wende J, Clark CR, et al. Feasability of using the Med-eMonitor™ system in the treatment of schizophrenia: a pilot study. Drug Inf J. 2003;38:1–8.
11.
go back to reference Artinian N, Harden J, Kronenberg M, et al. Pilot study of a web-based compliance monitoring evice for patients with congestive heart failure. In Paper presented at international congress of schizophrenia research 2005; San Antoinio. Artinian N, Harden J, Kronenberg M, et al. Pilot study of a web-based compliance monitoring evice for patients with congestive heart failure. In Paper presented at international congress of schizophrenia research 2005; San Antoinio.
12.
go back to reference Moss AR, Hahn JA, Perry S, et al. Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study. Clin Infect Dis. 2004;39(8):1190–8.PubMedCrossRef Moss AR, Hahn JA, Perry S, et al. Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study. Clin Infect Dis. 2004;39(8):1190–8.PubMedCrossRef
13.
go back to reference Parienti JJ, Das-Douglas M, Massari V, et al. Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS One. 2008;3(7):e2783.PubMedCrossRef Parienti JJ, Das-Douglas M, Massari V, et al. Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS One. 2008;3(7):e2783.PubMedCrossRef
14.
go back to reference Bangsberg D, Hecht F, Charlebois E, et al. Comparing objectives measures of adherence to HIV antiretroviral therapy: electronic medication monitors and unannounced pill counts. AIDS Behav. 2001;5(3):275–81.CrossRef Bangsberg D, Hecht F, Charlebois E, et al. Comparing objectives measures of adherence to HIV antiretroviral therapy: electronic medication monitors and unannounced pill counts. AIDS Behav. 2001;5(3):275–81.CrossRef
15.
go back to reference Samet JH, Sullivan LM, Traphagen ET, et al. Measuring adherence among HIV-infected persons: is MEMS consummate technology? AIDS Behav. 2000;5(1):21–30.CrossRef Samet JH, Sullivan LM, Traphagen ET, et al. Measuring adherence among HIV-infected persons: is MEMS consummate technology? AIDS Behav. 2000;5(1):21–30.CrossRef
16.
go back to reference Holden RJ, Karsh BT. The technology acceptance model: its past and its future in health care. J Biomed Inform. 2010;43(1):159–72.PubMedCrossRef Holden RJ, Karsh BT. The technology acceptance model: its past and its future in health care. J Biomed Inform. 2010;43(1):159–72.PubMedCrossRef
17.
go back to reference Drews FA, Picciano P, Agutter J, Syroid N, Westenskow DR, Strayer DL. Development and evaluation of a just-in-time support system. Hum Factors. 2007;49(3):543–51.PubMedCrossRef Drews FA, Picciano P, Agutter J, Syroid N, Westenskow DR, Strayer DL. Development and evaluation of a just-in-time support system. Hum Factors. 2007;49(3):543–51.PubMedCrossRef
18.
go back to reference Wyatt JC, Sullivan F. eHealth and the future: promise or peril? BMJ. 2005;331(7529):1391–3. Wyatt JC, Sullivan F. eHealth and the future: promise or peril? BMJ. 2005;331(7529):1391–3.
19.
go back to reference Kaplan WA. Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries? Glob Health. 2006;2:9.CrossRef Kaplan WA. Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries? Glob Health. 2006;2:9.CrossRef
20.
go back to reference Goldie SJ, Paltiel AD, Weinstein MC, et al. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Am J Med. 2003;115(8):632–41.PubMedCrossRef Goldie SJ, Paltiel AD, Weinstein MC, et al. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Am J Med. 2003;115(8):632–41.PubMedCrossRef
21.
go back to reference Nachega JB, Leisegang R, Bishai D, et al. Association of antiretroviral therapy adherence and health care costs. Ann Intern Med. 2010;152(1):18–25.PubMed Nachega JB, Leisegang R, Bishai D, et al. Association of antiretroviral therapy adherence and health care costs. Ann Intern Med. 2010;152(1):18–25.PubMed
Metadata
Title
Real-Time Electronic Adherence Monitoring is Feasible, Comparable to Unannounced Pill Counts, and Acceptable
Authors
Jessica E. Haberer
Gregory K. Robbins
Michele Ybarra
Alexandra Monk
Kathleen Ragland
Sheri D. Weiser
Mallory O. Johnson
David R. Bangsberg
Publication date
01-02-2012
Publisher
Springer US
Published in
AIDS and Behavior / Issue 2/2012
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-011-9933-y

Other articles of this Issue 2/2012

AIDS and Behavior 2/2012 Go to the issue